~~<i id='0E7DDB9790'><strike id='0E7DDB9790'><tt id='0E7DDB9790'><pre id='0E7DDB9790'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：Wikipedia 2025-09-05 04:56:32 - browse：49

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Americans' trust in science, scientist continues decline: Report

Wikipedia

focus

hotspot

entertainment

knowledge

NewresearchledbyStanfordneuro-oncologistMichelleMonjeshineslightontheelectrochemicalsignalingpathway

WSS

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

What PEPFAR has meant on the ground in Ukraine

All of Us, NIH's precision medicine initiative, gets a big boost

Spinal cord stimulation reduces pain in amputees, study finds

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

explore

explore

Wikipedia

Sports medicine is finally prioritizing gender equality

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

In age of alternative facts, a scholarly course on calling out crap

What PEPFAR has meant on the ground in Ukraine

Hepatitis C has a cure — but many Americans still lack access to it

Kidney transplant patients stopped immunosuppressants in trial

Drug repurposing or repositioning? The language matters

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Dobbs anniversary: the lost opportunity of abortion as health care

Life sciences investors close nearly $6 billion in new funds

focus

Medicare must police algorithms in Medicare Advantage, Dems say

Gene therapy’s promise and the high cost of hope

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

What causes an itch? Researchers may have solved the mystery

What PEPFAR has meant on the ground in Ukraine

The health care issue Democrats can’t solve: hospital reform

hotspot

entertainment

entertainment

knowledge